P213 POSTERS (OM) case. The authors treat reconstructed posterior canal wall with the temporal fascial flap (TFF) and the temporal periosteal flap (TPF).
Objective: Report our results with Florical in stabilizing hearing loss in patients with early otosclerosis.
Method: A retrospective chart review was undertaken of patients with early otosclerosis treated with Florical. Using a paired t test, comparisons were made in amount of change between speech recognition threshold (SRT) and pure tone average (PTA) air-bone gap (ABG). A P-value of < .05 was considered statistically significant.
Results: Eight patients with 10 affected ears were studied. Average age was 44.1 ± 14.2 years old. No statistically significant decline was detected at 3, 6, and 12 months in SRT (P-value = 1.0, .68, .68, respectively) and PTA ABG (P-value = .46, .61, and .39, respectively) . Baseline average ABG was 10.5 ± 8.7 dB. Eight of the 10 ears experienced improvement of PTA ABG (mean = 6.6 ± 5.7 dB). One patient (1 ear) had complete closure of the PTA ABG. Mean follow-up was 5.7 months. No patients discontinued use of Florical because of adverse side effects. Only 2 patients (25%) reported dyspepsia.
Conclusion:
Our early experience demonstrates that Florical may prevent hearing deterioration and even reversal of early conductive hearing loss. It may be better tolerated than other sodium fluoride preparations, as calcium carbonate may help to alleviate the gastrointestinal side effects associated with sodium fluoride administration.
Otology/Neurotology Foil Technique for Optimized Cosmetic Results in CI Surgery

M. Katharina Pein, MD (presenter); Kerstin Hoffmann
Objective: Cosmetic results in bilateral cochlear implantations strongly depend on the symmetric position of the coils, not only the scars. The primary purpose of this work is to present a simple method to find the correct position for the second coil and to ensure symmetry in single and 2-step implantation procedures.
Method: In a proof-of-principle study, 5 CI patients were supplied with a second CI. Important reference points were marked using a silicone foil. The foil then was transferred to the opposite side, and according to reference points, the exact symmetric position of the speech-processor coil could be located.
Results: Coil positions were measured postoperatively, and photographs were taken to evaluate success. In all patients, the second coil could be placed symmetrically to the opposite side. The location error is less then 5 mm, measured with the pre-or intraoperatively drawn transparency. The cosmetic outcome was associated with a high degree of patient satisfaction in all patients. Furthermore, silicone transparencies have excellent hygienic properties and are easily to sterilize.
Conclusion:
The introduced silicone foil technique is easy and quickly implemented. Other intraoperative methods in coil positioning, such as those based on photography, are less accurate and depend highly on the surgeon's capabilities. Especially in bilateral CI-surgery, silicone transparencies should become a standard technique for higher patient satisfaction and outstanding cosmetic results.
Otology/Neurotology Glomus Jugulare Tumors: A Series of 24 Cases
Pedro Alberto Escada, MD, PhD (presenter); Gonçalo Neto de Almeida; José Pratas Vital; Gabriel Branco, MD Objective: Describe the surgical technique and experience of a neurotology surgical team working in Lisbon, Portugal, in the surgical treatment of glomus jugulare tumors.
Method: The retrospective study included 24 patients operated between 1988 and 2007. Data were obtained from the medical records and after a recent evaluation of the patients. The outcome measures were: clinical manifestations, preoperative embolization and surgical technique, tumor removal, morbidity, mortality, and evolution of residual lesions.
Results: Symptoms included hearing loss (33%); pulsatile tinnitus (21%); and cranial nerves X (29%), VII (25%), and XII (21%) paralysis. Preoperative embolization was performed in 92% of the cases, and the surgical technique was the infratemporal fossa aproach type A in all the cases. Total removal of the tumor was obtained in 11 (45%) cases. Only 21% of the patients had a grade III-IV House-Brackmann or worse after 12 months. Two patients died from pneumonia. Five (21%) of the patients required a second surgery, but only one patient required radiotherapy after incomplete removal of the tumor.
Conclusion: Glomus jugulare tumors and their treatment have significant morbidity and mortality. Neurotology surgical POSTERS teams should be created to develop surgical expertise and competence in the treatment of the disease in order to offer the best options to these patients.
Otology/Neurotology Hearing Loss and Cochlear Pathology in a Type II Diabetic Mouse Model
Sean Miller, MD (presenter); Flint Boettcher; Grady Phillips; Michael Anne Gratton, PhD Objective: 1) Determine whether a type II diabetic mouse model demonstrates hearing loss. 2) Examine cochlear ultrastructure of a type II diabetic mouse model for evidence of pathology.
Method: The Lepr db /Lepr db (db/db) mouse has a leptin receptor point mutation which manifests as polyphagia, hyperglycemia, and obesity, mimicking type II diabetes. Db/db and wild type mice from the parent strain underwent auditory brainstem response measurements followed by cochlear ultrastructure analysis using scanning and transmission electron microscopy.
Results: At 12 weeks of age, the mutant animals demonstrate a profound hearing loss from 8 to 32 kHz, which is in contrast to published data of a 10 dB shift at 8 kHz and 30 dB shift at 16 to 32 kHz for age-matched, wild type C57BL/6J counterparts. In addition, fine structure analysis reveals evidence of morphological alterations in multiple locations within the cochlea, including loss of neuron density in the spiral ganglion, stria vascularis edema, and endothelial abnormalities within strial capillaries. Agematched controls are without similar ultrastructural changes. Scanning electron microscopy reveals no evidence of hair cell loss or other identifiable abnormalities.
Conclusion: This is the first demonstration of cochlear pathophysiology in a genetically derived type II diabetic mouse model. Use of the db/db mouse provides an opportunity to investigate the underlying mechanism of type II diabetes associated hearing loss.
Otology/Neurotology Hearing Loss as Factor That Influences the Quality of Life in Tinnitus Patients
Letícia Petersen Schmidt Rosito, MD (presenter); Bruna Vanni; Konrado Deutsch;
Vanessa de Brito Belline
Objective: Tinnitus is a sensation of noise. In most cases it is accompanied by hearing loss, but it can be an independent symptom occurring in patients with normal hearing. We want to compare the impact of tinnitus on quality of life in patients with or without associated hearing loss.
Method:
We selected patients with chronic and disturbing tinnitus. They underwent audiometry and answered the Tinnitus Handicap Inventory (THI) in order to evaluate and quantify the impact of tinnitus. The criterion defined as the threshold of hearing loss records was less than 25 dB at all frequencies in either ear.
Results: From January 2005 to January 2011, 308 patients were included. The patients were divided into 2 groups: 1) with hearing loss (n = 272), and 2) with normal hearing (n = 34). Among patients with normal hearing, the average score on the THI was 33.8, whereas among patients with hearing loss, the average was 42.33, P = .04 (t test).
Conclusion:
Patients with hearing loss have a mean THI significantly higher than patients with normal hearing. Thus, we found that although the tinnitus alone would lead to worse quality of life of patients, hearing loss is one factor that contributes additionally and independently.
Otology/Neurotology Hearing Outcomes in Canal Wall Down Mastoidectomy with Cartilage Tympanoplasty
Eric Thorpe, MD (presenter); Sam J. Marzo, MD Objective: 1) Measure the overall postoperative hearing after both canal wall down mastoidectomy and cartilage tympanoplasty. 2) Assess the air-bone gap postoperatively in patients after both canal wall down mastoidectomy and cartilage tympanoplasty.
Method: A retrospective review of all patients who underwent canal wall down mastoidectomy with a cartilage tympanoplasty during the time period of 2000 to 2010. Cases of the appropriate surgery were chosen by operative reports. Indications for surgery largely included cholesteatoma, chronic otitis media, or both.
Results: A total of 39 patients were found to have the procedure in question with 30 patients having full audiograms for review. Preand postoperative pure tone averages (PTA) along with air-bone gaps (ABG) were reviewed at 500 Hz, 1,000 Hz, 2,000 Hz, and 4,000 Hz. Postoperative PTA showed an improvement of 7.2 dB over preoperative PTA. Postoperative ABG showed an improvement of 4.53 dB over preoperative ABG. The ABG improvement was found to be statistically significant with a P value of .0285.
Conclusion:
The results of this study demonstrate that hearing results following a canal wall down mastoidectomy along with a cartilage tympanoplasty not only have acceptable hearing results but also actually show an improvement over preoperative audiological function.
Otology/Neurotology Hearing Recovery by Local IGF1 Therapy in Sudden Deafness
Takayuki Nakagawa, MD, PhD (presenter); Tatsunori Sakamoto; Yasuhiko Tabata; Harukazu Hiraumi, MD; Juichi Ito, MD, PhD; Norio Yamamoto, MD, PhD Objective: Evaluate hearing recovery following local application of insulin-like growth factor 1 (IGF1) in patients with
